These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 26208482)
21. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer. Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K Cells; 2020 Jan; 9(1):. PubMed ID: 31963582 [TBL] [Abstract][Full Text] [Related]
22. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Nojima K; Hochegger H; Saberi A; Fukushima T; Kikuchi K; Yoshimura M; Orelli BJ; Bishop DK; Hirano S; Ohzeki M; Ishiai M; Yamamoto K; Takata M; Arakawa H; Buerstedde JM; Yamazoe M; Kawamoto T; Araki K; Takahashi JA; Hashimoto N; Takeda S; Sonoda E Cancer Res; 2005 Dec; 65(24):11704-11. PubMed ID: 16357182 [TBL] [Abstract][Full Text] [Related]
23. Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells. Chen YY; Chiang SY; Lin JG; Yang JS; Ma YS; Liao CL; Lai TY; Tang NY; Chung JG Anticancer Res; 2010 Mar; 30(3):945-51. PubMed ID: 20393018 [TBL] [Abstract][Full Text] [Related]
24. Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB. Aasland D; Götzinger L; Hauck L; Berte N; Meyer J; Effenberger M; Schneider S; Reuber EE; Roos WP; Tomicic MT; Kaina B; Christmann M Cancer Res; 2019 Jan; 79(1):99-113. PubMed ID: 30361254 [TBL] [Abstract][Full Text] [Related]
25. DNA damage response and transcription. Lagerwerf S; Vrouwe MG; Overmeer RM; Fousteri MI; Mullenders LH DNA Repair (Amst); 2011 Jul; 10(7):743-50. PubMed ID: 21622031 [TBL] [Abstract][Full Text] [Related]
26. Increased oxidative stress in AOA3 cells disturbs ATM-dependent DNA damage responses. Kobayashi J; Saito Y; Okui M; Miwa N; Komatsu K Mutat Res Genet Toxicol Environ Mutagen; 2015 Apr; 782():42-50. PubMed ID: 25868131 [TBL] [Abstract][Full Text] [Related]
27. DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs. Beljanski V; Marzilli LG; Doetsch PW Mol Pharmacol; 2004 Jun; 65(6):1496-506. PubMed ID: 15155842 [TBL] [Abstract][Full Text] [Related]
28. Multiple DNA damage-dependent and DNA damage-independent stress responses define the outcome of ATR/Chk1 targeting in medulloblastoma cells. Krüger K; Geist K; Stuhldreier F; Schumacher L; Blümel L; Remke M; Wesselborg S; Stork B; Klöcker N; Bormann S; Roos WP; Honnen S; Fritz G Cancer Lett; 2018 Aug; 430():34-46. PubMed ID: 29753759 [TBL] [Abstract][Full Text] [Related]
29. Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response. Chu PM; Chiou SH; Su TL; Lee YJ; Chen LH; Chen YW; Yen SH; Chen MT; Chen MH; Shih YH; Tu PH; Ma HI Radiat Oncol; 2011 Jan; 6():7. PubMed ID: 21244709 [TBL] [Abstract][Full Text] [Related]
30. The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases. Vidal B; Parra M; Jardí M; Saito S; Appella E; Muñoz-Cánoves P Thromb Haemost; 2005 Mar; 93(3):584-91. PubMed ID: 15735814 [TBL] [Abstract][Full Text] [Related]
31. Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation. Saha J; Wang M; Cucinotta FA DNA Repair (Amst); 2013 Dec; 12(12):1143-51. PubMed ID: 24238855 [TBL] [Abstract][Full Text] [Related]
32. Casticin Induces DNA Damage and Impairs DNA Repair in Human Bladder Cancer TSGH-8301 Cells. Huang AC; Cheng YD; Huang LH; Hsiao YT; Peng SF; Lu KW; Lien JC; Yang JL; Lin TS; Chung JG Anticancer Res; 2019 Apr; 39(4):1839-1847. PubMed ID: 30952724 [TBL] [Abstract][Full Text] [Related]
33. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance. Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615 [TBL] [Abstract][Full Text] [Related]
34. Roles of DNA repair and reductase activity in the cytotoxicity of the hypoxia-activated dinitrobenzamide mustard PR-104A. Gu Y; Patterson AV; Atwell GJ; Chernikova SB; Brown JM; Thompson LH; Wilson WR Mol Cancer Ther; 2009 Jun; 8(6):1714-23. PubMed ID: 19509245 [TBL] [Abstract][Full Text] [Related]
35. Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death. Calderón-Montaño JM; Burgos-Morón E; Orta ML; Pastor N; Perez-Guerrero C; Austin CA; Mateos S; López-Lázaro M Pharmacol Rep; 2012; 64(6):1515-25. PubMed ID: 23406762 [TBL] [Abstract][Full Text] [Related]
36. Repair of endogenous DNA base lesions modulate lifespan in mice. Meira LB; Calvo JA; Shah D; Klapacz J; Moroski-Erkul CA; Bronson RT; Samson LD DNA Repair (Amst); 2014 Sep; 21():78-86. PubMed ID: 24994062 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways. Ito SS; Nakagawa Y; Matsubayashi M; Sakaguchi YM; Kobashigawa S; Matsui TK; Nanaura H; Nakanishi M; Kitayoshi F; Kikuchi S; Kajihara A; Tamaki S; Sugie K; Kashino G; Takahashi A; Hasegawa M; Mori E; Kirita T J Biol Chem; 2020 Sep; 295(37):12946-12961. PubMed ID: 32675286 [TBL] [Abstract][Full Text] [Related]
38. DNA alkylation lesion repair: outcomes and implications in cancer chemotherapy. Peng Y; Pei H J Zhejiang Univ Sci B; 2021 Jan; 22(1):47-62. PubMed ID: 33448187 [TBL] [Abstract][Full Text] [Related]
39. ATR/ATM-Mediated Phosphorylation of BRCA1 T1394 Promotes Homologous Recombinational Repair and G Foo TK; Vincelli G; Huselid E; Her J; Zheng H; Simhadri S; Wang M; Huo Y; Li T; Yu X; Li H; Zhao W; Bunting SF; Xia B Cancer Res; 2021 Sep; 81(18):4676-4684. PubMed ID: 34301763 [TBL] [Abstract][Full Text] [Related]
40. DNA-PKcs, a novel functional target of acriflavine, mediates acriflavine's p53-dependent synergistic anti-tumor efficiency with melphalan. Cao J; Lin G; Gong Y; Pan P; Ma Y; Huang P; Ying M; Hou T; He Q; Yang B Cancer Lett; 2016 Dec; 383(1):115-124. PubMed ID: 27693638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]